Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Sci Rep ; 9(1): 13449, 2019 09 17.
Artigo em Inglês | MEDLINE | ID: mdl-31530834

RESUMO

The Burkholderia cepacia complex (Bcc) is a family of closely related bacterial pathogens that are the causative agent of deadly human infections. Virulence in Bcc species has been shown to be controlled by the CepI/CepR quorum sensing (QS) system, which is mediated by an N-acyl L-homoserine lactone (AHL) signal (C8-AHL) and its cognate LuxR-type receptor (CepR). Chemical strategies to block QS in Bcc members would represent an approach to intercept this bacterial communication process and further delineate its role in infection. In the current study, we sought to identify non-native AHLs capable of agonizing or antagonizing CepR, and thereby QS, in a Bcc member. We screened a library of AHL analogs in cell-based reporters for CepR, and identified numerous highly potent CepR agonists and antagonists. These compounds remain active in a Bcc member, B. multivorans, with one agonist 250-fold more potent than the native ligand C8-AHL, and can affect QS-controlled motility. Further, the CepR antagonists prolong C. elegans survival in an infection model. These AHL analogs are the first reported non-native molecules that both directly modulate CepR and impact QS-controlled phenotypes in a Bcc member, and represent valuable chemical tools to assess the role of QS in Bcc infections.


Assuntos
Proteínas de Bactérias/antagonistas & inibidores , Complexo Burkholderia cepacia/efeitos dos fármacos , Complexo Burkholderia cepacia/patogenicidade , Percepção de Quorum/efeitos dos fármacos , Acil-Butirolactonas/metabolismo , Animais , Proteínas de Bactérias/agonistas , Proteínas de Bactérias/genética , Proteínas de Bactérias/metabolismo , Infecções por Burkholderia/microbiologia , Caenorhabditis elegans/efeitos dos fármacos , Avaliação Pré-Clínica de Medicamentos , Escherichia coli/genética , Genes Reporter , Ligantes , Percepção de Quorum/fisiologia , beta-Galactosidase/genética
2.
Mol Nutr Food Res ; 62(9): e1700992, 2018 05.
Artigo em Inglês | MEDLINE | ID: mdl-29573169

RESUMO

SCOPE: This study was undertaken to expand our insights into the mechanisms involved in the tolerance to resveratrol (RSV) that operate at system-level in gut microorganisms and advance knowledge on new RSV-responsive gene circuits. METHODS AND RESULTS: Whole genome transcriptional profiling was used to characterize the molecular response of Lactobacillus plantarum WCFS1 to RSV. DNA repair mechanisms were induced by RSV and responses were triggered to decrease the load of copper, a metal required for RSV-mediated DNA cleavage, and H2 S, a genotoxic gas. To counter the effects of RSV, L. plantarum strongly up- or downregulated efflux systems and ABC transporters pointing to transport control of RSV across the membrane as a key mechanism for RSV tolerance. L. plantarum also downregulated tRNAs, induced chaperones, and reprogrammed its transcriptome to tightly control ammonia levels. RSV induced a probiotic effector gene and a likely deoxycholate transporter, two functions that improve the host health status. CONCLUSION: Our data identify novel protective mechanisms involved in RSV tolerance operating at system level in a gut microbe. These insights could influence the way RSV is used for a better management of gut microbial ecosystems to obtain associated health benefits.


Assuntos
Antioxidantes/metabolismo , Proteínas de Bactérias/metabolismo , Reparo do DNA , Regulação Bacteriana da Expressão Gênica , Lactobacillus plantarum/metabolismo , Modelos Biológicos , Resveratrol/metabolismo , Animais , Proteínas de Bactérias/agonistas , Proteínas de Bactérias/antagonistas & inibidores , Proteínas de Bactérias/genética , Transporte Biológico , Cobre/química , Cobre/metabolismo , Ácidos Cumáricos , Suplementos Nutricionais , Perfilação da Expressão Gênica , Ontologia Genética , Humanos , Sulfeto de Hidrogênio/antagonistas & inibidores , Sulfeto de Hidrogênio/metabolismo , Lactobacillus plantarum/crescimento & desenvolvimento , Lactobacillus plantarum/isolamento & purificação , Probióticos , Propionatos/metabolismo , RNA Bacteriano/antagonistas & inibidores , RNA Bacteriano/metabolismo , RNA de Transferência/antagonistas & inibidores , RNA de Transferência/metabolismo , Saliva/microbiologia
3.
Future Med Chem ; 9(17): 1983-1994, 2017 11.
Artigo em Inglês | MEDLINE | ID: mdl-29076756

RESUMO

AIM: Resistance to conventional antibiotics has spurred interest in exploring new antimicrobial strategies. Suppressing quorum sensing within biofilm is a promising antimicrobial strategy. LasR in quorum sensing system of the Gram-negative bacteria, Pseudomonas aeruginosa, directly enhances virulence and antibiotic resistance, with QscR as its indirect suppressor, so targeting both of them can synergistically take the effect. METHODOLOGY/RESULTS: An in silico protocol combining pharmacophores with molecular docking was applied. Pharmacophores of QscR agonists and LasR antagonists were prepared for preliminary screening, followed by counter-screen using a pharmacophore model of LasR agonists and molecular docking of LasR. Four compounds with novel scaffolds were confirmed as potential biofilm inhibitors with preliminary experimental data. CONCLUSION: Novel biofilm inhibitors can be found with the method.


Assuntos
Antibacterianos/farmacologia , Proteínas de Bactérias/agonistas , Proteínas de Bactérias/antagonistas & inibidores , Biofilmes/efeitos dos fármacos , Pseudomonas aeruginosa/efeitos dos fármacos , Percepção de Quorum/efeitos dos fármacos , Proteínas Repressoras/agonistas , Transativadores/antagonistas & inibidores , Antibacterianos/química , Avaliação Pré-Clínica de Medicamentos , Testes de Sensibilidade Microbiana , Modelos Moleculares , Relação Estrutura-Atividade
4.
Molecules ; 22(1)2017 Jan 14.
Artigo em Inglês | MEDLINE | ID: mdl-28098806

RESUMO

Medicinal plants are frequently used for the treatment of various infectious diseases. The objective of this study was to evaluate the antibacterial activity and mode of action of Acacia nilotica and the antibiogram patterns of foodborne and clinical strains of Escherichia coli and Salmonella. The mechanism of action of acacia extracts against E. coli and Salmonella was elucidated by observing morphological damages including cell integrity and cell membrane permeability, as well as changes in cell structures and growth patterns in kill-time experiments. The clinical isolates of E. coli and Salmonella were found resistant to more of the tested antibiotics, compared to food isolates. Minimum inhibitory concentration and minimum bactericidal concentration of acacia leaf extracts were in the ranges of 1.56-3.12 mg/mL and 3.12-6.25 mg/mL, respectively, whereas pods and bark extracts showed somewhat higher values of 3.12-6.25 mg/mL and 6.25-12.5 mg/mL, respectively, against all tested pathogens. The release of electrolytes and essential cellular constituents (proteins and nucleic acids) indicated that acacia extracts damaged the cellular membrane of the pathogens. These changes corresponded to simultaneous reduction in the growth of viable bacteria. This study indicates that A. nilotica can be a potential source of new antimicrobials, effective against antibiotic-resistant strains of pathogens.


Assuntos
Acacia/química , Antibacterianos/farmacologia , Proteínas de Bactérias/agonistas , DNA Bacteriano/agonistas , Escherichia coli/efeitos dos fármacos , Salmonella/efeitos dos fármacos , Antibacterianos/isolamento & purificação , Proteínas de Bactérias/metabolismo , Membrana Celular/efeitos dos fármacos , Membrana Celular/metabolismo , Permeabilidade da Membrana Celular/efeitos dos fármacos , DNA Bacteriano/metabolismo , Farmacorresistência Bacteriana Múltipla/efeitos dos fármacos , Escherichia coli/crescimento & desenvolvimento , Escherichia coli/metabolismo , Escherichia coli/ultraestrutura , Testes de Sensibilidade Microbiana , Extratos Vegetais/química , Folhas de Planta/química , Salmonella/crescimento & desenvolvimento , Salmonella/metabolismo , Salmonella/ultraestrutura
5.
Genet Mol Res ; 14(2): 6723-32, 2015 Jun 18.
Artigo em Inglês | MEDLINE | ID: mdl-26125881

RESUMO

We explored the mechanism of the development from sensitivity to resistance to carbapenem in Pseudomonas aeruginosa. Two P. aeruginosa strains were collected during treatment with carbapenem. Strain homology was investigated using pulsed-field gel electrophoresis. Porin oprD2 expression was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The minimum inhibitory concentrations (MICs) of imipenem and meropenem with or without MC207110 were determined using the agar dilution method. The expression level of efflux pump mRNA was tested using real-time polymerase chain reaction. Metallo-lactamases (MBLs) were screened using the EDTA-disk synergy test. Genes encoding MBLs were amplified and then analyzed by DNA sequencing. The two treated strains belonged to the same pulsed-field gel electrophoresis type. The SDS-PAGE profile of the P. aeruginosa strains revealed that the 46-kDa membrane protein OprD2 of IMP(R)MEM(R) type strains was lost, whereas OprD2 of 1 IMP(S)MEM(S) strain was normal. With or without MC207110 treatment, the MIC of carbapenem-resistant P. aeruginosa decreased by 4-fold, while the MIC of carbapenem-sensitive P. aeruginosa did not. Compared with the carbapenem-sensitive strain, MexX mRNA expression in the carbapenem-resistant strain increased by 102.5-fold, while the mRNA expression of other efflux pumps did not markedly increase. Neither carbapenem-resistant nor carbapenem-sensitive P. aeruginosa produced MBL. The mechanism of development from sensitivity to resistance of P. aeruginosa to carbapenem during carbapenem treatment is due to porin oprD2 loss and an increased expression level of MexXY-OprM.


Assuntos
Antibacterianos/farmacologia , Proteínas da Membrana Bacteriana Externa/genética , Proteínas de Bactérias/genética , Regulação Bacteriana da Expressão Gênica , Proteínas de Membrana Transportadoras/genética , Porinas/genética , Pseudomonas aeruginosa/genética , Resistência beta-Lactâmica/genética , Proteínas da Membrana Bacteriana Externa/agonistas , Proteínas da Membrana Bacteriana Externa/metabolismo , Proteínas de Bactérias/agonistas , Proteínas de Bactérias/metabolismo , Dipeptídeos/farmacologia , Combinação de Medicamentos , Eletroforese em Gel de Campo Pulsado , Eletroforese em Gel de Poliacrilamida , Imipenem/farmacologia , Proteínas de Membrana Transportadoras/agonistas , Proteínas de Membrana Transportadoras/metabolismo , Meropeném , Testes de Sensibilidade Microbiana , Porinas/deficiência , Pseudomonas aeruginosa/efeitos dos fármacos , Pseudomonas aeruginosa/metabolismo , Tienamicinas/farmacologia , Resistência beta-Lactâmica/efeitos dos fármacos , beta-Lactamases/genética , beta-Lactamases/metabolismo
6.
Bioorg Med Chem ; 19(16): 4812-9, 2011 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-21798749

RESUMO

Quorum sensing (QS) is a cell-cell signaling mechanism that allows bacteria to monitor their population size and alter their behavior at high cell densities. Gram-negative bacteria use N-acylated L-homoserine lactones (AHLs) as their primary signals for QS. These signals are susceptible to lactone hydrolysis in biologically relevant media, and the ring-opened products are inactive QS signals. We have previously identified a range of non-native AHLs capable of strongly agonizing and antagonizing QS in Gram-negative bacteria. However, these abiotic AHLs are also prone to hydrolysis and inactivation and thereby have a relatively short time window for use (∼12-48 h). Non-native QS modulators with reduced or no hydrolytic instability could have enhanced potencies and would be valuable as tools to study the mechanisms of QS in a range of environments (for example, on eukaryotic hosts). This study reports the design and synthesis of two libraries of new, non-hydrolyzable AHL mimics. The libraries were screened for QS modulatory activity using LasR, LuxR, and TraR bacterial reporter strains, and several new, abiotic agonists and antagonists of these receptors were identified.


Assuntos
Acil-Butirolactonas/metabolismo , Desenho de Fármacos , Bactérias Gram-Negativas/efeitos dos fármacos , Percepção de Quorum/efeitos dos fármacos , Proteínas Repressoras/efeitos dos fármacos , Transativadores/efeitos dos fármacos , Acil-Butirolactonas/síntese química , Acil-Butirolactonas/química , Acil-Butirolactonas/farmacologia , Proteínas de Bactérias/agonistas , Proteínas de Bactérias/antagonistas & inibidores , Proteínas de Bactérias/efeitos dos fármacos , Proteínas de Bactérias/genética , Avaliação Pré-Clínica de Medicamentos , Estabilidade de Medicamentos , Genes Reporter/efeitos dos fármacos , Bactérias Gram-Negativas/fisiologia , Lactonas/metabolismo , Terapia de Alvo Molecular , Proteínas Repressoras/agonistas , Proteínas Repressoras/genética , Proteínas Repressoras/fisiologia , Transativadores/agonistas , Transativadores/antagonistas & inibidores , Transativadores/genética , Transativadores/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA